Post Content
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is among the best fundamentally strong penny stocks to invest in now. On April 30, TheFly reported that JPMorgan trimmed the price target on Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) from $11 to $10 and reiterated an Overweight rating. With the highest 1-year price target among analysts, the firm’s estimate implies 192.83% upside potential. Overall, the stock has a Buy rating from 38% of the analysts, with the remaining 63% neutral.
During a Morgan Stanley webcast on April 15, Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) highlighted its AI-powered drug discovery platform. The leadership outlined the way technology is being utilized for target identification, molecule design, and clinical development.
Billion Photos/Shutterstock.com
According to management, AI-driven initiatives have already resulted in a 30% to 50% improvement in patient enrollment. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) also adopts AI for protocol design and patient stratification. In contrast to industry norms of 2,500 to 5,000 compounds over a span of four to five years, the company accelerated a compound to clinical trials after designing nearly 330 molecules in a period of 17 months. With a focus on AI and an impressive quarterly revenue growth (YoY) of 681.70%, RXRX is among the best fundamentally strong penny stocks to invest in now.
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is a Utah-based clinical-stage biotechnology company specializing in the decoding of biology and chemistry. Founded in 2013, the company develops its solutions by integrating technological advancements.
While we acknowledge the potential of RXRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years
Disclosure: None. Follow Insider Monkey on Google News.